Related Experiment Video
Updated: Aug 19, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
Published on: July 23, 2010
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for
G W Demers1, E Espling, J B Harry
1Program in Cancer Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98040, USA.
Abstract:
Cells arrest in the G1 or G0 phase of the cell cycle in response to a variety of negative growth signals that induce arrest by different molecular pathways. The ability of human papillomavirus (HPV) oncogenes to bypass these signals and allow cells to progress into the S phase probably contributes to the neoplastic potential of the virus. The E7 protein of HPV-16 was able to disrupt the response of epithelial cells to three different negative growth arrest signals: quiescence imposed upon suprabasal epithelial cells, G1 arrest induced by DNA damage, and inhibition of DNA synthesis caused by treatment with transforming growth factor beta. The same set of mutated E7 proteins was able to abrogate all three growth arrest signals. Mutant proteins that failed to abrogate growth arrest signals were transformation deficient and included E7 proteins that bound retinoblastoma protein in vitro. In contrast, HPV-16 E6 was able to bypass only DNA damage-induced G1 arrest, not suprabasal quiescence or transforming growth factor beta-induced arrest. The E6 and E7 proteins from the low-risk virus HPV-6 were not able to bypass any of the growth arrest signals.
Insights
Human papillomavirus (HPV) E7 oncogenes disrupt cell cycle arrest signals, promoting cell proliferation and contributing to cancer. Mutated E7 proteins that bind retinoblastoma protein are key to this effect.
Area of Science:
- Cell Biology
- Virology
- Molecular Biology
Background:
- Cells normally arrest in G1/G0 phase due to negative growth signals.
- Human papillomavirus (HPV) oncogenes may overcome these signals, contributing to neoplastic potential.
- Understanding how viral proteins affect cell cycle regulation is crucial.
Purpose of the Study:
- To investigate the ability of HPV oncogenes, specifically E7 and E6 proteins, to bypass distinct negative growth arrest signals in epithelial cells.
- To determine the role of retinoblastoma protein binding in the function of HPV E7.
- To compare the effects of high-risk (HPV-16) and low-risk (HPV-6) HPV proteins on cell cycle control.
Main Methods:
- Assessing the ability of HPV-16 E7 and E6 proteins to abrogate specific cell cycle arrest signals (suprabasal quiescence, DNA damage-induced G1 arrest, TGF-β-induced arrest).
- Utilizing mutated E7 proteins to identify critical functional domains, including retinoblastoma protein binding.
- Comparing the effects of HPV-16 proteins with those of HPV-6 proteins.
Main Results:
- HPV-16 E7 abrogated all three tested negative growth arrest signals.
- Mutant E7 proteins unable to abrogate growth arrest, including those that did not bind retinoblastoma protein, were transformation deficient.
- HPV-16 E6 only bypassed DNA damage-induced G1 arrest.
- HPV-6 E6 and E7 proteins did not bypass any of the tested growth arrest signals.
Conclusions:
- The E7 protein of high-risk HPV-16 plays a significant role in disrupting multiple cell cycle checkpoints, likely contributing to its oncogenic potential.
- Retinoblastoma protein binding is essential for the ability of HPV-16 E7 to abrogate growth arrest signals.
- Low-risk HPV-6 proteins lack the ability to significantly interfere with these cellular growth control mechanisms.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

